Characterizing Ligand-Gated Ion Channel Receptors with Genetically Encoded Ca.sup.++ Sensors

• Published in: PloS one Vol. 6; no. 1; p. e16519
• Main Authors: Yamauchi, John G, Nemecz, Ákos, Nguyen, Quoc Thang, Muller, Arnaud, Schroeder, Lee F, Talley, Todd T, Lindstrom, Jon, Kleinfeld, David, Taylor, Palmer
• Format: Journal Article
• Language: English
• Published: Public Library of Science 28.01.2011
• Subjects: Fluorescence
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0016519

We present a cell based system and experimental approach to characterize agonist and antagonist selectivity for ligand-gated ion channels (LGIC) by developing sensor cells stably expressing a Ca.sup.2+ permeable LGIC and a genetically encoded Förster (or fluorescence) resonance energy transfer (FRET)-based calcium sensor. In particular, we describe separate lines with human [alpha]7 and human [alpha]4[beta]2 nicotinic acetylcholine receptors, mouse 5-HT.sub.3A serotonin receptors and a chimera of human [alpha]7/mouse 5-HT.sub.3A receptors. Complete concentration-response curves for agonists and Schild plots of antagonists were generated from these sensors and the results validate known pharmacology of the receptors tested. Concentration-response relations can be generated from either the initial rate or maximal amplitudes of FRET-signal. Although assaying at a medium throughput level, this pharmacological fluorescence detection technique employs a clonal line for stability and has versatility for screening laboratory generated congeners as agonists or antagonists on multiple subtypes of ligand-gated ion channels. The clonal sensor lines are also compatible with in vivo usage to measure indirectly receptor activation by endogenous neurotransmitters.